Hong Kong Stocks Rise Midday as Biotech Index Surges 2.99% on Gene Therapy Policy Update

HK501.06%

According to Zhitong Finance, Hong Kong's Hang Seng Index rose 0.83% to 23,542 points in midday trading on July 6, while the Hang Seng Tech Index climbed 1.16%. Midday trading volume reached 186.2 billion Hong Kong dollars.

The uptick was driven by a regulatory update: China's drug regulator recently released draft guidelines optimizing the review and approval process for cell and gene therapy drugs, covering measures to encourage innovation and streamline clinical trials. The Hang Seng BioTech Innovation Index surged 2.99% in response, with major biotech stocks gaining sharply.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments